Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

98 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-05-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project will assess the utility of a brief motivational intervention to engage smokers with schizophrenia in treatment for tobacco dependence treatment. It is hypothesized that a brief motivational intervention will be more effective in engaging smokers with schizophrenia to tobacco dependence treatment than an educational intervention. The educational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by teaching subjects about the negative effects of smoking and the success of tobacco dependence treatment. The motivational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by increasing subjects' motivation to change by presenting objective and personalized information regarding their smoking behaviors in a non-judgmental and supportive manner.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Examining Persistence in Smokers With Schizophrenia

NCT03346291

Smoking Cessation Schizophrenia Schizo Affective Disorder

COMPLETED NA

Very Low Nicotine Cigarettes in Smokers With Schizophrenia

NCT02019459

Tobacco Dependence

COMPLETED PHASE2

Knowledge and Perception of Smoking Risks/Consequences

NCT00686101

Cigarette Smoking Schizophrenia

COMPLETED

Predictors of Treatment Outcome for Smokers With and Without Schizophrenia

NCT00501007

Tobacco Dependence

COMPLETED

Cigarette Smoking in Smokers With and Without Schizophrenia

NCT04001114

Tobacco Dependence Schizophrenia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

See Brief Summary above.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia Schizoaffective Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Motivational Interviewing

Group Type EXPERIMENTAL

Motivational Interviewing

Intervention Type BEHAVIORAL

Motivational Interviewing

Psychoeducation

Group Type ACTIVE_COMPARATOR

Psychoeducation

Intervention Type BEHAVIORAL

Psychoeducation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motivational Interviewing

Intervention Type BEHAVIORAL

Psychoeducation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current smokers must be over the age of 18,
* Must have a diagnosis of schizophrenia or schizoaffective disorder
* Must smoke at least 10 cigarettes per day
* Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22